Print Page   |   Sign In   |   Register
Blog Home All Blogs
Search all posts for:   


View all (131) posts »

Stock Market Manager Weekly Update: September 24th, 2018

Posted By Administration, Thursday, September 27, 2018

SMM Logo






 Weekly Update: September 24th, 2018








Latest Happenings

Breaking News


New Distribution Partner for SMM

In addition to our ongoing growth in distribution we have added anew very important distribution partner in Quote Media.

They are the premier provider of quote and news services to the financial Industry in North America. They current have some 675 subscribers and publishers of their quote and news feeds including major stock exchanges like NASDAQ and the Toronto Stock Exchange and an extensive list of portfolio managers both in North America and abroad.

All Research updates, releases and news articles will automatically be uploaded from SMM to Quote Media through our RSS feed and will be then ticker tagged and distributed across the Quote Media network in real Time.

This will begin next week and is provided by SMM at no additional charge.

If you have any questions, please feel free to email or give me a call.


Trickle Research Issues Research Note 9-24-18 
AzurRx Biopharma, Inc.
12-24 Month Price Target $10.25

AzurRX made the following announcement this morning regarding positive results from their PhaseIIa clinical trial for MS1819-SD a treatment for chronic pancreatitis.

This announcement is one the major milestones we referenced in the initial coverage as a potential catalyst to much higher valuations of the

company. This is very positive news. To put this into perspective, as of this writing, the stock is trading up on the news, but currently the market cap of the stock is about $62 million. Recall, in the original research, we noted a company called Anthera Pharmaceuticals, Inc. (symbol: ANTH) that was developing a similar treatment and at times traded with a market cap in excess of $3 billion. Those trials subsequently failed. In short, again in line with our initial coverage, we think this clinical trial success substantially raises the awareness

(and by extension the chances) of AZRX relative to potential deals and/or transactions will large pharma players. As the Company notes, this is a billion market that is currently being addressed by a treatment that is decades old and not viewed particularly favorably by the FDA because it is an animal-based solution that carries associated risks.

Again, we think this may be a watershed event for AZRX and we reiterate our target of $10.25, which frankly, may prove to be a bargain.

Click Here for Research Note


Greenridge Global LLC issues update 9-6-18
Full Share Holdings (HK:607)
Target $4.00

Nearing Resolution On CHS Deal

China High Speed Sale Update.  Fullshare has begun selling off non-core assets as required under the prospective deal.  Absent this, there has been little in the way of updates as Neoglory Prosperity Inc. [SZ: 2147] works on financial and regulatory issues on its end.  The potential sale will be terminated if a formal sale and purchase agreement is not entered into by September 30, 2018.  The outcome of this potential deal will have a significant impact on the future makeup of Fullshare. 

H1:18 Underperforms on CHS Weakness.  Fullshare reported H1:18 Revenue of RMB 3,883.89 million, a 19.7% decline from the year ago period.  China High Speed, which produces the bulk of the Company’s Revenue, saw sales decline 11.0% year-over-year, to RMB 3,466.79 million.  The decline was led by a 14.4% decline from its wind gear business.  Property sales fell sharply from the year ago period, as fewer projects saw deliveries during the first half of 2018.  Gross margins fell to 23.0% from 24.8% due to the lower Sales at CHS, where margins fell to 23.0% from 30.8% in the year ago period.  Fullshare reported a fair value change in financial assets of RMB 855.18 million, of which RMB 741.15 million was attributable to the share price increase of Zall Group [HK: 2098].  SG&A fell to RMB 845.52 million, from RMB 914.08 million in the year ago period.  Other Income of RMB 434.11 million was primarily from interest and investment income, while Other Expenses of RMB 71.05 million included a RMB 66.0 million impairment on its Hin Sang Group holdings [HK: 6893] investment.  Finance expenses increased to RMB 499.56 million on higher interest payments from CHS.  Net Profit for the period was RMB 550.60 million, or RMB 2.79 per share.

Model Update.  We made a number of changes to our model, including reducing the Revenue outlook, in large part because of recent CHS performance.  As noted previously, our model could change substantially based on the outcome of the proposed CHS deal.  Also of note is the share price of Zall has tumbled thus far in the second half of 2018, which if the price stays in this area would produce a multi-billion RMB loss in H2:18.

Maintaining Rating & Target.  As we wait for the outcome of the proposed CHS deal, Fullshare management has been deploying capital into targeted tourism investments, the education sector and the distressed real estate market, all of which should lift future earnings.  Based on information currently available, we are reiterating our Buy rating and HK$4.00 target price on Fullshare Holdings.  Our target price is based on a discount model, which assumes Fullshare will acquire RMB 1.5 billion of EBITDA annually, at 5x EBITDA that will grow 15% per year, discounted at 6% annually.


Greenridge Global LLC issues update 8-3-18
Guangdong Land Holdings
target $4.75

Click Here for Research Note

GZ Acquisitions Close After H1:18 Results.  GDL reported H1:18 Revenue of HK$10.42 million, which was comprised of HK$8.87 million from the sale of old staff quarters and HK$1.55 million of rental income.  Higher Selling Expenses of HK$7.77 million were related to the pre-sale activity of the Buxin project, while Administrative Expenses of HK$40.94 million were up due to the fees incurred surrounding the Baohuaxuan and Zhuguanglu Project acquisitions, which closed on July 11.  This was partially offset by HK$28.90 million in interest-related income.  Income taxes of HK$74.57 million included HK$77.17 million of over-provided land appreciation tax that was reversed following tax clearance from local tax authorities.  Net Income for the period was HK$62.40 million, or HK$3.65 cents per share.


Trickle Research Issues Earnings Update 8-23-18
PetroShare Corp 
12-24 Month Price Target $3.20
Click Here for Research Note

PetroShare had a much better quarter than we anticipated. We think its safe to say, that was the best quarter of their nascent existence. Keep in mind, the quarter did not include any contributions from Shook, which will commence in Q3, so all of the revenue was associated with small non-operated interests in the wells of others. To be honest, it’s a bit difficult to try projecting their participation in non-operated assets because they essentially amount to small fragments of a number of wells. Regardless, they realized more production than we were projecting from the non-operated segment, and interestingly enough, the numbers were also positively impacted by a good mix of oil to gas/NGL. Oil revenues were nearly 65% of the total, which was considerably better than the sub 40% oil mix for Q1F18. That was the best oil/gas ratio they have reported since the same quarter last year. Obviously, higher oil mix can be impactful in times of high relative oil prices. Again, we wish we could find a way to better project the non-operating segment in general, however, we expect the focus going to shift toward operated assets, so much of that difficulty should become less relevant as we move forward.

Trickle Research Discontinues Coverage
Barfresh Food Group Inc. (BRFH) *Premium »











(listing, quotes, news, research)







Aethlon Medical, Inc. (AEMD)





Assure Holdings, Inc. (ARHH)





Antibe Therapeutics, Inc (ATBPF)





AzuerRx Biopharma, Inc. (AZRX)




Camino Minerals Corp. (CAMZF)




Canbiola, Inc. (CANB)




News, Inc. (CIIX)




Command Center , Inc. (CCNI)





Endurance Exploration Group, Ltd (EXPL)





Ecom Products Group (EPGC)









Galaxy Gaming, Inc. (GLXZ)





Guangdong Land Holdings Limited (124) HK



Magnegas, Inc. (MNGA)





MOBI724 Global Solutions, Inc. (MOBIF)




New Jersey Mining Company (NJMC)




Petroshare Corp. (PRHR)





Social Reality, Inc. (SRAX)





Zynex, Inc. (ZYXI)









September 21st, 2018

This week, we provide top-five ranked VE data for our Industrial Products Sector stocks. We take a look at our latest data on Boingo Wireless $WIFI and provide a free download link for our stock report on the company. 

For Complete Report Click HERE


VALUATION WATCH: Overvalued stocks now make up 53.61% of our stocks assigned a valuation and 22.87% of those equities are calculated to be overvalued by 20% or more. Twelve sectors are calculated to be overvalued.  

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners


Black Swan Research Coverage and Subscription Service
Click Here>>


Event Calendar Updates

Trickle Research and GVC Capital
Rocky Mountain Microcap Conference October 9, 2018.
BlackHawk, Colorado at Ameristar Resort

On October 9, 2018, we will be holding Rocky Mountain Microcap Conference III.  The Conference will be held at the Ameristar Casino Resort Spa in Blackhawk, Colorado.  The agenda will be limited to just 13 public microcap companies.  The companies will present on a single track and each will be allotted a 25-minute presentation slot.  We hope to attract approximately 65-75 microcap investors, institutions and bankers who are close associates, clients and/or Trickle Research subscribers. Our spring conference had around 80 investor attendees).  We believe we will once again assemble a group of highly relevant microcap centric attendees.

Read More


Dawson James Securities 
Small Cap Growth Conference Oct 29-30
Wyndham Grand Hotel –Jupiter Florida

Full Day--Two Track Presentations from over 30 Companies in Healthcare/Technology & Consumer Sectors

Uplist “Bootcamp” for Invited Guests

Monday Evening Panel/Welcome Cocktails

Last Year’s event was attended by over 250 of our Institutional, Family Office and High Net Worth Clients

Click Here to Register

NIBA New York Conference Oct 31- Nov-1

We’ll be attending, as long standing members, and ready to assist and make introductions.
If anyone would like to set up a meeting to discuss our services or any related matters, please email me at

The National Investment Banking Association (NIBA) is proud to host its 145th investment conference on Oct 31- Nov-1, 2018 at the Crown Plaza at Times Square in New York City.  

If you would like to make a corporate presentation Click Here to download the Presenting Company Application

To register as an attendee click the button below

NIBA Registration




Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

SMM Distribution Update

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)       1,414

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Page                 (contacts)                              472

SMM Youtube Channel            (followers)                                 6

SMM Instagram                      (followers)                             131         

Direct Email                                                                 345,000

Total                                                                             353,485



This post has not been tagged.

Share |
Permalink | Comments (0)
Community Search
Sign In